Simon, T., Schmidt, M., Decarolis, B., Eggert, A., Berthold, F. and Hero, B. (2017). I-131-Meta-Iodobenzylguanidine (MIBG) Therapy Improves Survival in High-Risk Neuroblastoma Patients with MIBG Positive Residual Metastatic Disease. Pediatr. Blood Cancer, 64. S. S33 - 2. HOBOKEN: WILEY. ISSN 1545-5017

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Simon, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmidt, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Decarolis, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eggert, A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Berthold, F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hero, B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-213065
Journal or Publication Title: Pediatr. Blood Cancer
Volume: 64
Page Range: S. S33 - 2
Date: 2017
Publisher: WILEY
Place of Publication: HOBOKEN
ISSN: 1545-5017
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
Oncology; Hematology; PediatricsMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/21306

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item